COMP <GO>
INVX vs PG // PIOTROSKI F-SCORE QUALITY
Innovex International Inc. (NYSE) VS. Procter & Gamble Company (NYSE) • 15-METRIC TALLY: INVX 5
— PG 7
■ METRIC PARITY
LAST: $30.00 (-1.22%) • MKT CAP: $2.10B
piotroski-score
7/9
LAST: $160.59 (+1.47%) • MKT CAP: $372.21B
piotroski-score
7/9
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (INVX VS. PG)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | INVX | PG | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 31.00% | 51.20% | -20.20 | PG | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 9.90% | 25.40% | -15.50 | PG | /roic <GO> |
| EV/EBITDA & P/E Valuation | 15.8x | 16.2x | -0.40 | INVX | /valuation <GO> |
| Free Cash Flow Yield | 9.10% | 3.77% | +5.33 | INVX | /fcf-yield <GO> |
| Operating Margin | 13.60% | 24.30% | -10.70 | PG | /operating-margins <GO> |
| Net Profit Margin | 8.50% | 19.00% | -10.50 | PG | /net-margins <GO> |
| Revenue Growth (YoY) | 48.00% | 0.30% | +47.70 | INVX | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.65% | -2.65 | PG | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 7.96 | 5.59 | +2.37 | INVX | /balance-sheet <GO> |
| Piotroski F-Score Quality ACTIVE | 7/9 | 7/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 54.6 | 60.3 | -5.70 | PG | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 0.87 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 21.2x | 21.7x | -0.50 | INVX | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $2.10B | $372.21B | -$370.11B | PG | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | INVX REV | PG REV | INVX GROSS % | PG GROSS % | INVX FCF | PG FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $978.3M | $84.28B | 31.0% | 51.2% | $190.9M | $14.04B |
| FY 2024 | $660.8M | $84.04B | 35.2% | 51.4% | $93.4M | $16.52B |
| FY 2023 | $555.5M | $82.01B | — | — | $75.9M | $13.16B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
INVX // BETA —
PG // BETA 0.87